首页> 外文期刊>Journal of clinical laboratory analysis. >Correlation between TLR2, TLR3, TLR4, and TLR9 polymorphisms and susceptibility to and prognosis of severe hepatitis among the newborns
【24h】

Correlation between TLR2, TLR3, TLR4, and TLR9 polymorphisms and susceptibility to and prognosis of severe hepatitis among the newborns

机译:新生儿TLR2,TLR3,TLR4和TLR9多态性与重症肝炎的易感性和预后的相关性

获取原文
           

摘要

Background This study was aimed to explore how toll‐like receptor 2 ( TLR2) , TLR3 , TLR4 and TLR9 influenced the risk and prognosis of severe hepatitis among the Chinese newborns. Methods Altogether 135 newborns diagnosed with severe hepatitis and 140 healthy newborns were included in this study. Totally 12 single nucleotide polymorphisms (SNPs) within TLR2 , TLR3 , TLR4 , and TLR9 were chosen and genotyped by polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using the logistic regression. The univariate and multivariate analyses were used to analyze independent factors for prognosis of severe hepatitis among the Chinese newborns. Results The SNPs within TLR2 [ie, rs1898830 (AG) and rs3804100 (TC)], TLR3 [ie, rs1879026 (GT)], TLR4 [ie, rs2149356 (TG)], and TLR9 [ie, rs187084 (TC), rs352139 (AG), and rs352140 (CT)] were significantly associated with modified risk of neonatal severe hepatitis (all P 1.5] of newborns with severe hepatitis (all P Conclusions Certain SNPs and haplotypes within TLR2 , TLR3 , TLR4 , and TLR9 can be considered as the potentially treatment targets for neonatal severe hepatitis.
机译:背景本研究旨在探讨收费型受体2(TLR2),TLR3,TLR4和TLR9如何影响中国新生儿严重肝炎的风险和预后。方法本研究共纳入135例确诊为重型肝炎的新生儿和140例健康的新生儿。在TLR2,TLR3,TLR4和TLR9中总共选择了12个单核苷酸多态性(SNP),并通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)进行基因分型。使用logistic回归计算赔率(OR)和95%置信区间(CI)。采用单因素和多因素分析来分析中国新生儿重症肝炎预后的独立因素。结果TLR2 [即rs1898830(A> G)和rs3804100(T> C)],TLR3 [即rs1879026(G> T)],TLR4 [即rs2149356(T> G)]和TLR9 [即rs187084(T> C),rs352139(A> G)和rs352140(C> T)]与新生儿重症肝炎的风险降低有显着相关性(均为P 1.5)(所有P结论结论某些SNP TLR2,TLR3,TLR4和TLR9内的单倍型可以被认为是新生儿重症肝炎的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号